BRPI0513825A - combinações de epotilona - Google Patents
combinações de epotilonaInfo
- Publication number
- BRPI0513825A BRPI0513825A BRPI0513825-6A BRPI0513825A BRPI0513825A BR PI0513825 A BRPI0513825 A BR PI0513825A BR PI0513825 A BRPI0513825 A BR PI0513825A BR PI0513825 A BRPI0513825 A BR PI0513825A
- Authority
- BR
- Brazil
- Prior art keywords
- combinations
- epothilone
- epotilone
- retarding
- progression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMBINAçõES DE EPOTILONA. A invenção refere-se a combinações de (a) uma epotilona com (b) dois ou mais de outros agentes antineoplásicos para uso simultâneo, separado ou seqüencial, em particular para o retardo da progressão ou tratamento de uma doença proliferativa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59122504P | 2004-07-26 | 2004-07-26 | |
PCT/EP2005/008076 WO2006010585A1 (en) | 2004-07-26 | 2005-07-25 | Epothilone combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0513825A true BRPI0513825A (pt) | 2008-05-20 |
Family
ID=35058801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0513825-6A BRPI0513825A (pt) | 2004-07-26 | 2005-07-25 | combinações de epotilona |
Country Status (17)
Country | Link |
---|---|
US (1) | US20090041715A1 (pt) |
EP (1) | EP1773334A1 (pt) |
JP (1) | JP2008507573A (pt) |
KR (1) | KR20070037498A (pt) |
CN (1) | CN1988904A (pt) |
AU (1) | AU2005266484A1 (pt) |
BR (1) | BRPI0513825A (pt) |
CA (1) | CA2573949A1 (pt) |
IL (1) | IL180604A0 (pt) |
MA (1) | MA28812B1 (pt) |
MX (1) | MX2007000971A (pt) |
NO (1) | NO20071038L (pt) |
RU (1) | RU2007106931A (pt) |
TN (1) | TNSN07025A1 (pt) |
TW (1) | TW200616626A (pt) |
WO (1) | WO2006010585A1 (pt) |
ZA (1) | ZA200700201B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2009114A1 (en) * | 2007-06-29 | 2008-12-31 | Bayer Schering Pharma Aktiengesellschaft | Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones |
JP2011503075A (ja) * | 2007-11-09 | 2011-01-27 | ノバルティス アーゲー | エポチロンまたはエポチロン誘導体誘発下痢を処置するためのコルチコステロイド |
AU2011255647A1 (en) | 2010-05-18 | 2012-11-15 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
US8974811B2 (en) | 2013-03-14 | 2015-03-10 | Hikma Pharmaceuticals | Stabilized pharmaceutical formulations comprising antineoplastic compounds |
CN107041886A (zh) * | 2016-02-06 | 2017-08-15 | 北京华昊中天生物技术有限公司 | 脱环氧埃坡霉素衍生物制剂、制备及其治疗肿瘤的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000034437A2 (en) * | 1998-12-08 | 2000-06-15 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
EE05417B1 (et) * | 2001-03-14 | 2011-06-15 | Bristol-Myers Squibb Company | Epotilooni analoogide ja kemoterapeutikumide kombinatsiooni kasutamine teraapias |
-
2005
- 2005-07-25 WO PCT/EP2005/008076 patent/WO2006010585A1/en active Application Filing
- 2005-07-25 US US11/658,357 patent/US20090041715A1/en not_active Abandoned
- 2005-07-25 AU AU2005266484A patent/AU2005266484A1/en not_active Abandoned
- 2005-07-25 RU RU2007106931/15A patent/RU2007106931A/ru not_active Application Discontinuation
- 2005-07-25 MX MX2007000971A patent/MX2007000971A/es not_active Application Discontinuation
- 2005-07-25 BR BRPI0513825-6A patent/BRPI0513825A/pt not_active IP Right Cessation
- 2005-07-25 CA CA002573949A patent/CA2573949A1/en not_active Abandoned
- 2005-07-25 TW TW094125050A patent/TW200616626A/zh unknown
- 2005-07-25 EP EP05776218A patent/EP1773334A1/en not_active Withdrawn
- 2005-07-25 JP JP2007522997A patent/JP2008507573A/ja active Pending
- 2005-07-25 KR KR1020077001843A patent/KR20070037498A/ko not_active Application Discontinuation
- 2005-07-25 CN CNA2005800253095A patent/CN1988904A/zh active Pending
-
2007
- 2007-01-08 IL IL180604A patent/IL180604A0/en unknown
- 2007-01-08 ZA ZA200700201A patent/ZA200700201B/en unknown
- 2007-01-25 TN TNP2007000025A patent/TNSN07025A1/en unknown
- 2007-02-21 MA MA29697A patent/MA28812B1/fr unknown
- 2007-02-23 NO NO20071038A patent/NO20071038L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL180604A0 (en) | 2008-03-20 |
CA2573949A1 (en) | 2006-02-02 |
EP1773334A1 (en) | 2007-04-18 |
MA28812B1 (fr) | 2007-08-01 |
AU2005266484A1 (en) | 2006-02-02 |
CN1988904A (zh) | 2007-06-27 |
TNSN07025A1 (en) | 2008-06-02 |
MX2007000971A (es) | 2007-04-10 |
US20090041715A1 (en) | 2009-02-12 |
KR20070037498A (ko) | 2007-04-04 |
JP2008507573A (ja) | 2008-03-13 |
TW200616626A (en) | 2006-06-01 |
RU2007106931A (ru) | 2008-09-10 |
WO2006010585A1 (en) | 2006-02-02 |
NO20071038L (no) | 2007-04-26 |
ZA200700201B (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20170633A1 (no) | Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff . | |
BRPI0717845A2 (pt) | Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos | |
BRPI0618473A2 (pt) | combinações e métodos de uso de um oligodeoxinucleotìdeo imunomodulador | |
CY1110559T1 (el) | Συνδυασμοι που περιλαμβανουν εποθιλονες και αναστολεις πρωτεϊνικων τυροσινικων κινασων και φαρμακευτικες χρησεις αυτων | |
EA200802332A1 (ru) | Пирролопиримидины и их применение | |
ECSP10010548A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
EA200602047A1 (ru) | Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака | |
HN2005029978A (es) | Formulaciones | |
EA200701918A1 (ru) | Белок липокалин | |
BRPI0820967A2 (pt) | Uso de uma composição, composição farmacêutica e método para tratamento, melhora ou profilaxia dos sintomas de uma doença inflamatória | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
ECSP088745A (es) | Derivados sustituidos de cromanol y su uso | |
CL2012002887A1 (es) | Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer. | |
EA200900767A1 (ru) | Антагонистические антитела против ephb3 | |
BRPI0911203A2 (pt) | peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo. | |
CL2007002671A1 (es) | Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc. | |
BR112021025537A2 (pt) | Azacitidina em combinação com venetoclax, gilteritinibe, midostaurina ou outros compostos para o tratamento de leucemia ou síndrome mielodisplásica | |
BRPI0718469A2 (pt) | Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto. | |
BRPI0511475A (pt) | combinação, composição farmacêutica, uso de uma combinação, e, método para o tratamento de cáncer | |
TR201901390T4 (tr) | Demodikoza karşı madde. | |
DK1861080T3 (da) | Idebenon til behandling af muskeldystrofier | |
BRPI0513825A (pt) | combinações de epotilona | |
CL2007001542A1 (es) | Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas. | |
UY29417A1 (es) | Agentes endoparasiticidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |